Business · 1 sources covering this

NIT, IISER researchers patent cotarnine-derived oral cancer formulation

The patented formulation showed activity against oral cancer cells, researchers said, but further preclinical studies are needed to establish its safety and efficacy.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
NIT, IISER researchers patent cotarnine-derived oral cancer formulation
The patented formulation showed activity against oral cancer cells, researchers said, but further preclinical studies are needed to establish its safety and efficacy.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/89dc1c7330af5aa2aa58f1bec678b0a138a5d796"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="NIT, IISER researchers patent cotarnine-derived oral cancer formulation"></iframe>

NIT, IISER researchers patent cotarnine-derived oral cancer formulation

How 1 sources are covering this

NIT, IISER researchers patent cotarnine-derived oral cancer formulation

More from Business

Business Standard poll: RBI may hike repo rate by 25 bps in October meet

No fuel supply restrictions imposed across retail network: Nayara Energy

VB-G RAM G: Work demand from households rises 34% to 15.64 mn in September

Tennessee fails to execute Christa Pike after 2 lethal injections: What happens next as per Tennessee law?

Reader

Trust & legal

Across the network